Summary
Cardinal Health, Inc. (CAH) has disclosed via an 8-K filing on April 8, 2005, that one of its subsidiaries has received a subpoena from the Attorney General’s Office of the State of New York. This subpoena is part of a broad industry inquiry that appears to be examining the secondary market within the wholesale pharmaceutical industry. Cardinal Health has indicated that it is one of several entities to have received a similar subpoena and intends to cooperate fully with the New York Attorney General's investigation. While the filing does not provide details on the specific nature of the inquiry or potential implications, investors should be aware of this ongoing regulatory scrutiny within the wholesale pharmaceutical sector.
Key Highlights
- 1Cardinal Health's subsidiary received a subpoena from the New York Attorney General's Office.
- 2The subpoena is part of a broad industry inquiry into the secondary market of the wholesale pharmaceutical industry.
- 3Cardinal Health believes it is one of multiple parties to have received such a subpoena.
- 4The company intends to be fully responsive to the New York Attorney General's investigation.
- 5The filing does not specify the exact nature or potential impact of the inquiry.